Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KDM6B | O15054 | 1/20 | 0.50 |
| ▸ | TET3 | O43151 | 1/20 | 0.50 |
| ▸ | KDM4A | O75164 | 1/20 | 0.50 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM5A | P29375 | 1/20 | 0.50 |
| ▸ | KDM5C | P41229 | 1/20 | 0.50 |
| ▸ | ASPH | Q12797 | 1/20 | 0.50 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.50 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.50 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.50 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.50 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.50 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.50 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13621658 | 0.85 | NR3C2 (0.44) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL5525023 | 0.83 | KDM4E (0.47) | KDM4EALDH1A1KDM6BTET3KDM4A | |
| SCHEMBL24252514 | 0.82 | ALDH1A1 (0.41) | KDM4EALDH1A1MAPTPTGS1PTGS2 | |
| SCHEMBL15858773 | 0.82 | ACACB (0.51) | KDM4EALDH1A1KDM6BMAPTKDM5C | |
| SCHEMBL221963 | 0.80 | ALDH1A1 (0.55) | KDM4EALDH1A1KDM6BTET3KDM4A | |
| SCHEMBL30281240 | 0.80 | ALDH1A1 (0.55) | KDM4EALDH1A1KDM6BTET3KDM4A | |
| SCHEMBL15562032 | 0.80 | HSD17B10 (0.55) | KDM4EALDH1A1KDM6BTET3KDM4A | |
| SCHEMBL743556 | 0.80 | KDM4E (0.47) | KDM4EALDH1A1KDM6BTET3KDM4A | |
| SCHEMBL15562033 | 0.80 | HSD17B10 (0.55) | KDM4EALDH1A1KDM6BTET3KDM4A | |
| Hydrochloric Acid SCHEMBL968208 | 0.79 | ALDH1A1 (0.53) | KDM4EALDH1A1KDM6BTET3KDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158025-A1 | GALACTOKINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH | 2023-05-25 | — | — | US | disclosed |
| US-9799839-B2 | Organometallic compound and organic light-emitting diode comprising the same | Samsung Diplay Co., Ltd. (KR) | 2017-10-24 | — | — | US | disclosed |
| US-9799839-B2 | Organometallic compound and organic light-emitting diode comprising the same | Samsung Diplay Co., Ltd. (KR) | 2017-10-24 | — | — | US | disclosed |
| US-9691992-B2 | Organic light-emitting diode | SAMSUNG DISPLEY CO., LTD. (KR) | 2017-06-27 | — | — | US | disclosed |
| US-9691992-B2 | Organic light-emitting diode | SAMSUNG DISPLEY CO., LTD. (KR) | 2017-06-27 | — | — | US | disclosed |
| US-9691992-B2 | Organic light-emitting diode | SAMSUNG DISPLEY CO., LTD. (KR) | 2017-06-27 | — | — | US | disclosed |
| US-20140209880-A1 | ORGANIC LIGHT-EMITTING DIODE | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-07-31 | — | — | US | disclosed |
| US-20140209880-A1 | ORGANIC LIGHT-EMITTING DIODE | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-07-31 | — | — | US | disclosed |
| US-20140209880-A1 | ORGANIC LIGHT-EMITTING DIODE | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-07-31 | — | — | US | disclosed |
| US-20140183467-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-07-03 | — | — | US | disclosed |
| CN-1315859-C | Lincomycin derivatives possessing antibacterial activity | VICURON PHARM INC (US) | 2007-05-16 | — | — | CN | disclosed |
| US-7199105-B2 | Lincomycin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS, INC. (US) | 2007-04-03 | — | — | US | disclosed |
| US-7164011-B2 | Lincomycin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS, INC. (US) | 2007-01-16 | — | — | US | disclosed |
| EP-1654268-A2 | LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | Vicuron Pharmaceuticals, Inc. (US) | 2006-05-10 | — | — | EP | disclosed |
| CN-1681832-A | Lincomycin derivatives possessing antibacterial activity | VICURON PHARM INC (US) | 2005-10-12 | — | — | CN | disclosed |
| EP-1529052-A2 | LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | Vicuron Pharmaceuticals, Inc. (US) | 2005-05-11 | — | — | EP | disclosed |
| WO-2005007665-A2 | LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2005-01-27 | — | — | WO | disclosed |
| US-20040230046-A1 | Lincomycin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. | 2004-11-18 | — | — | US | disclosed |
| US-20040116690-A1 | Lincomycin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. | 2004-06-17 | — | — | US | disclosed |
| WO-2004016632-A2 | LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS, INC. (US) | 2004-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040230046-A1 | Lincomycin derivatives possessing antibacterial activity | NRDC, NISCH, CLSPN | KDM4E 3921/4885ALDH1A1 2737/4885KDM6B 4020/4885 |
| US-20230158025-A1 | GALACTOKINASE INHIBITORS | GALK1, GCK, GCKR | KDM4E 2218/4885ALDH1A1 3139/4885KDM6B 2216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.